GENERICS supplier Amneal Pharmaceuticals has announced a full review of its Range Expansion Program (REP) with the aim of providing a "complete dispensary matrix for all off-patent products," according to md Gavin Upiter.
Upiter said on average 90 SKUs can be removed from the dispensary, improving efficiency in ordering, shelf space and stock holding costs.
He said Amneal's in-house DAA solution can also increase average pharmacy margin by $75k annually.
The above article was sent to subscribers in Pharmacy Daily's issue from 28 Sep 16
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 28 Sep 16
